Trademark: 85525635
Word
ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
Status Date
Monday, July 1, 2013
Filing Date
Thursday, January 26, 2012
Abandoned Date
Thursday, May 16, 2013
42 Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use for pharmaceutical research and development
"IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL"
Jul 1, 2013
Abandonment Notice Mailed - Failure To Respond
Jul 1, 2013
Abandonment - Failure To Respond Or Late Response
Mar 12, 2013
Teas Change Of Correspondence Received
Nov 15, 2012
Notification Of Final Refusal Emailed
Nov 15, 2012
Final Refusal E-Mailed
Nov 15, 2012
Final Refusal Written
Nov 14, 2012
Teas/Email Correspondence Entered
Nov 13, 2012
Correspondence Received In Law Office
Nov 13, 2012
Teas Response To Office Action Received
Jul 10, 2012
Assigned To Examiner
May 18, 2012
Notification Of Non-Final Action E-Mailed
May 18, 2012
Non-Final Action E-Mailed
May 18, 2012
Non-Final Action Written
May 5, 2012
Assigned To Examiner
Jan 30, 2012
New Application Office Supplied Data Entered In Tram
Jan 30, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
